WESTFIELD CAPITAL MANAGEMENT CO LP - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for Ascendis Pharma A/S (ASND)

Filing Manager: WESTFIELD CAPITAL MANAGEMENT CO LP
Reporting Manager: Westfield Capital Management Company, L.P.
Security: Ascendis Pharma A/S Common Stock
Symbol: ASND
Shares outstanding: 60.2M shares
Disclosed Ownership: 5.53M shares
Ownership: 9.18%
Form type: SCHEDULE 13G/A
Date filed: 2/11/2025, 09:15 AM
Date of event: Dec 31, 2024
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Westfield Capital Management Company, L.P.	9.18%	5.53M	3.87M	0	Brandi McMahon	Vice President, Deputy Chief Compliance Officer